Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

ClinicalTrials.gov ID: NCT03159403

Public ClinicalTrials.gov record NCT03159403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Orbactiv® for the Treatment of Infections Presumed or Confirmed to be Caused by Gram Positive Bacteria in a Real World Setting

Study identification

NCT ID
NCT03159403
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

  • Oritavancin Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2017
Primary completion
Feb 14, 2018
Completion
Mar 7, 2018
Last update posted
Mar 11, 2018

2017 – 2018

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Birmingham Infectious Disease and Infusion Birmingham Alabama 35243
Santa Barbara Cottage Hospital Santa Barbara California 93105
Florida Infectious Disease Care Fort Myers Florida 33912
Infectious Diseases Associates of North Central Florida, LLC Ocala Florida 34471
WellStar Health System - Kennestone Marietta Georgia 30060
Snake River Research, PLLC Idaho Falls Idaho 83404
St. Vincent Hospital and Health Care Center, Inc. Indianapolis Indiana 46260
Methodist Jennie Edmundson Hospital Council Bluffs Iowa 51503
IDC Clinical Research, LLC Wichita Kansas 67214
Clinical Infectious Disease Specialists Las Vegas Nevada 89128
New York-Presbyterian Brooklyn Methodist Hospital Brooklyn New York 11215
Erie County Medical Center Buffalo New York 14215
Trinity Health Medical Group Minot North Dakota 58701
Infectious Diseases Consultants of OKC Oklahoma City Oklahoma 73109
TruCare Internal Medicine and Infectious Diseases DuBois Pennsylvania 15801
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Center for Infectious Diseases & Travel Medicine El Paso Texas 79902
Houston Center For Infectious Diseases The Woodlands Texas 77380
Infectious Disease and Pulmonary Victoria Texas 77901
Foot & Ankle Institute St. George Utah 84770

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03159403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03159403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →